Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Eyepoint Pharmaceuticals Inc (EYPT)

Eyepoint Pharmaceuticals Inc (EYPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Eyepoint Pharmaceuticals Inc 480 PLEASANT STREET WATERTOWN MA 02472 USA

www.eyepointpharma.com Employees: 165 P: 617-926-5000 F: 617-926-5050

Sector:

Medical

Description:

EyePoint Pharmaceuticals Inc. operates as a biopharmaceutical company. It engaged in the development of drug devices to treat debilitating diseases of the eye disorders and other chronic conditions. The company's product candidate consists of DEXYCU(TM). EyePoint Pharmaceuticals Inc., formerly known as pSivida Corp., is headquartered in Watertown, MA.

Key Statistics

Overview:

Market Capitalization, $K 759,576
Enterprise Value, $K 659,876
Shares Outstanding, K 68,927
Annual Sales, $ 43,270 K
Annual Net Income, $ -130,870 K
Last Quarter Sales, $ 5,330 K
Last Quarter Net Income, $ -59,430 K
EBIT, $ -189,060 K
EBITDA, $ -193,470 K
60-Month Beta 1.85
% of Insider Shareholders 4.46%
% of Institutional Shareholders 99.41%
Float, K 65,853
% Float 95.54%
Short Volume Ratio 0.66

Growth:

1-Year Return -8.28%
3-Year Return 139.31%
5-Year Return 147.93%
5-Year Revenue Growth 112.42%
5-Year Earnings Growth 51.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.85 on 08/06/25
Next Earnings Date 11/05/25
Earnings Per Share ttm -2.68
EPS Growth vs. Prev Qtr -30.77%
EPS Growth vs. Prev Year -46.55%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 12/09/20

EYPT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -63.80%
Return-on-Assets % -50.72%
Profit Margin % -302.45%
Debt/Equity 0.00
Price/Sales 19.74
Price/Cash Flow N/A
Price/Book 3.47
Book Value/Share 3.58
Interest Coverage -13,077.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar